Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Sorbonne Université · Hôpital Saint-Antoine · +28 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
165
total citations
- FWCI
- 129.57
- Percentile
- 100%
- References
- 23
Citations per year
Authors
29Topics & keywords
Topics
Keywords
- Nivolumab
- Ipilimumab
- Medicine
- Open label
- Colorectal cancer
- Microsatellite instability
- Oncology
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.